Resources

Publications

05/20/2021
- Oncology
Rate of Incidental Germline Findings Detected by Tumor-Normal Matched Sequencing in Cancer Types Lacking Hereditary Cancer Testing Guidelines
ASCO Annual Meeting 2021
05/20/2021
- Oncology
The TIME Trial Network to Facilitate Rapid Clinical Trial Activation, Patient Screening, and Enrollment in Molecularly Targeted Trials
ASCO Annual Meeting 2021
05/20/2021
- Oncology
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology (IO) Biomarkers
ASCO Annual Meeting 2021
04/14/2021
- Oncology
Novel Targetable FGFR2 and FGFR3 Alterations in Glioblastoma Associate With Aggressive Phenotype and Distinct Gene Expression Programs
Acta Neuropathologica Communications
04/13/2021
- Oncology
Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome
Cell
03/17/2021
- Oncology
Non-secretory Multiple Myeloma With Unusual TFG-ALK Fusion Showed Dramatic Response to ALK Inhibition
npj Genomic Medicine
03/10/2021
- Oncology
Transferring Diagnostic and Prognostic Molecular Models Across Technological Platforms
AACR Annual Meeting 2021
03/10/2021
- Oncology
Incidence of Molecular Alterations in KRAS and Other Known Cancer Genes in Patients With Pancreatic Cancer Assessed With a Commercial Genomic Profiling Panel Compared to TCGA Results
AACR Annual Meeting 2021
03/10/2021
- Oncology
Characterizing Differences in Checkpoint Inhibitor Biomarkers in a Real-world Cohort of Stage III and IV Non-small Cell Lung Cancer Patients
AACR Annual Meeting 2021
03/10/2021
- Oncology
Genomic Characterization and Monitoring Molecular Response to Treatment in African American (AA) Advanced Prostate Cancer (PC) Patients (Pts) via Next-Generation Sequencing (NGS): Real-world Experience in a Safety Net Hospital Oncology Clinic
AACR Annual Meeting 2021

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25